SCHEMBL31756966

SCHEMBL31756966

CCCC1CCCN1[C@H](CC)C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA3 P07451 1/20 0.43
CA4 P22748 1/20 0.43
CA6 P23280 1/20 0.43
CA5A P35218 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA13 Q8N1Q1 1/20 0.43
CA14 Q9ULX7 1/20 0.43
CA5B Q9Y2D0 1/20 0.43
DPP4 P27487 5/20 0.33
FAP Q12884 3/20 0.33
DPP8 Q6V1X1 3/20 0.33
DPP9 Q86TI2 3/20 0.33
DPP7 Q9UHL4 3/20 0.33
HTT P42858 1/20 0.33
BCHE P06276 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28568525 1.00 LMNA (0.43) LMNACA12CA1CA2CA3
SCHEMBL30271973 1.00 LMNA (0.43) LMNACA12CA1CA2CA3
SCHEMBL29431839 1.00 LMNA (0.43) LMNACA12CA1CA2CA3
SCHEMBL30381336 0.86 ACE (0.36) LMNACA12CA1CA2CA3
SCHEMBL28605644 0.86 ACE (0.36) LMNACA12CA1CA2CA3
SCHEMBL23930400 0.79 LMNA (0.46) LMNACA12CA1CA2CA3
SCHEMBL20630145 0.79 LMNA (0.46) LMNACA12CA1CA2CA3
SCHEMBL11680756 0.77 PSEN1 (0.37) POLBS1PR1S1PR3S1PR5SMN1; SMN2
SCHEMBL6977660 0.75 CA1 (0.38) LMNACA12CA1CA2CA3
SCHEMBL2026586 0.74 KDM4E (0.46) LMNACA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12516021-B2 Method for preparing brivaracetam and intermediate thereof SHANGHAI SYNCORES TECHNOLOGIES INC. LTD. (CN) 2026-01-06 US disclosed